Invus Public Equities, L.P. 13D/13G Filings for IGM Biosciences, Inc. (IGMS)

Invus Public Equities, L.P. 13D and 13G filings for IGM Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-08-02
6:41 pm
Purchase
2024-07-2513GIGM Biosciences, Inc.
IGMS
Invus Public Equities, L.P.3,330,422
9.900%
3,330,422increase
(New Position)
Filing